BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 27491809)

  • 1. Genetic events in the progression of adenoid cystic carcinoma of the breast to high-grade triple-negative breast cancer.
    Fusco N; Geyer FC; De Filippo MR; Martelotto LG; Ng CK; Piscuoglio S; Guerini-Rocco E; Schultheis AM; Fuhrmann L; Wang L; Jungbluth AA; Burke KA; Lim RS; Vincent-Salomon A; Bamba M; Moritani S; Badve SS; Ichihara S; Ellis IO; Reis-Filho JS; Weigelt B
    Mod Pathol; 2016 Nov; 29(11):1292-1305. PubMed ID: 27491809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic landscape of adenoid cystic carcinoma of the breast.
    Martelotto LG; De Filippo MR; Ng CK; Natrajan R; Fuhrmann L; Cyrta J; Piscuoglio S; Wen HC; Lim RS; Shen R; Schultheis AM; Wen YH; Edelweiss M; Mariani O; Stenman G; Chan TA; Colombo PE; Norton L; Vincent-Salomon A; Reis-Filho JS; Weigelt B
    J Pathol; 2015 Oct; 237(2):179-89. PubMed ID: 26095796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MYBL1 rearrangements and MYB amplification in breast adenoid cystic carcinomas lacking the MYB-NFIB fusion gene.
    Kim J; Geyer FC; Martelotto LG; Ng CK; Lim RS; Selenica P; Li A; Pareja F; Fusco N; Edelweiss M; Kumar R; Gularte-Merida R; Forbes AN; Khurana E; Mariani O; Badve S; Vincent-Salomon A; Norton L; Reis-Filho JS; Weigelt B
    J Pathol; 2018 Feb; 244(2):143-150. PubMed ID: 29149504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenoid cystic carcinomas constitute a genomically distinct subgroup of triple-negative and basal-like breast cancers.
    Wetterskog D; Lopez-Garcia MA; Lambros MB; A'Hern R; Geyer FC; Milanezi F; Cabral MC; Natrajan R; Gauthier A; Shiu KK; Orr N; Shousha S; Gatalica Z; Mackay A; Palacios J; Reis-Filho JS; Weigelt B
    J Pathol; 2012 Jan; 226(1):84-96. PubMed ID: 22015727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenoid cystic carcinomas of the salivary gland, lacrimal gland, and breast are morphologically and genetically similar but have distinct microRNA expression profiles.
    Andreasen S; Tan Q; Agander TK; Steiner P; Bjørndal K; Høgdall E; Larsen SR; Erentaite D; Olsen CH; Ulhøi BP; von Holstein SL; Wessel I; Heegaard S; Homøe P
    Mod Pathol; 2018 Aug; 31(8):1211-1225. PubMed ID: 29467480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of MYB oncogene in transformed adenoid cystic carcinomas reveals distinct pathways of tumor progression.
    Costa AF; Altemani A; García-Inclán C; Fresno F; Suárez C; Llorente JL; Hermsen M
    Lab Invest; 2014 Jun; 94(6):692-702. PubMed ID: 24732452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resolving quandaries: basaloid adenoid cystic carcinoma or breast cylindroma? The role of massively parallel sequencing.
    Fusco N; Colombo PE; Martelotto LG; De Filippo MR; Piscuoglio S; Ng CK; Lim RS; Jacot W; Vincent-Salomon A; Reis-Filho JS; Weigelt B
    Histopathology; 2016 Jan; 68(2):262-71. PubMed ID: 25951887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MYB-NFIB gene fusion in adenoid cystic carcinoma of the breast with special focus paid to the solid variant with basaloid features.
    D'Alfonso TM; Mosquera JM; MacDonald TY; Padilla J; Liu YF; Rubin MA; Shin SJ
    Hum Pathol; 2014 Nov; 45(11):2270-80. PubMed ID: 25217885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MYB and MYBL1 in adenoid cystic carcinoma: diversity in the mode of genomic rearrangement and transcripts.
    Togashi Y; Dobashi A; Sakata S; Sato Y; Baba S; Seto A; Mitani H; Kawabata K; Takeuchi K
    Mod Pathol; 2018 Jun; 31(6):934-946. PubMed ID: 29410490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequent NFIB-associated Gene Rearrangement in Adenoid Cystic Carcinoma of the Vulva.
    Xing D; Bakhsh S; Melnyk N; Isacson C; Ho J; Huntsman DG; Gilks CB; Ronnett BM; Horlings HM
    Int J Gynecol Pathol; 2017 May; 36(3):289-293. PubMed ID: 27662035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of MYB expression and MYB-NFIB gene fusions in adenoid cystic carcinoma and other salivary neoplasms.
    Brill LB; Kanner WA; Fehr A; Andrén Y; Moskaluk CA; Löning T; Stenman G; Frierson HF
    Mod Pathol; 2011 Sep; 24(9):1169-76. PubMed ID: 21572406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical behavior and genomic features of the so-called adenoid cystic carcinomas of the solid variant with basaloid features.
    Schwartz CJ; Brogi E; Marra A; Da Cruz Paula AF; Nanjangud GJ; da Silva EM; Patil S; Shah S; Ventura K; Razavi P; Norton L; D'alfonso T; Weigelt B; Pareja F; Reis-Filho JS; Wen HY
    Mod Pathol; 2022 Feb; 35(2):193-201. PubMed ID: 34599282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The repertoire of somatic genetic alterations of acinic cell carcinomas of the breast: an exploratory, hypothesis-generating study.
    Guerini-Rocco E; Hodi Z; Piscuoglio S; Ng CK; Rakha EA; Schultheis AM; Marchiò C; da Cruz Paula A; De Filippo MR; Martelotto LG; De Mattos-Arruda L; Edelweiss M; Jungbluth AA; Fusco N; Norton L; Weigelt B; Ellis IO; Reis-Filho JS
    J Pathol; 2015 Oct; 237(2):166-78. PubMed ID: 26011570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MYB RNA In Situ Hybridization Is a Useful Diagnostic Tool to Distinguish Breast Adenoid Cystic Carcinoma From Other Triple-negative Breast Carcinomas.
    Butcher MR; White MJ; Rooper LM; Argani P; Cimino-Mathews A
    Am J Surg Pathol; 2022 Jul; 46(7):878-888. PubMed ID: 35522890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenoid cystic carcinoma and basaloid carcinoma of the breast: A clinicopathological study.
    Marco V; Garcia F; Rubio IT; Soler T; Ferrazza L; Roig I; Mendez I; Andreu X; Mínguez CG; Tresserra F
    Rev Esp Patol; 2021; 54(4):242-249. PubMed ID: 34544554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Problematic breast tumors reassessed in light of novel molecular data.
    Pareja F; Weigelt B; Reis-Filho JS
    Mod Pathol; 2021 Jan; 34(Suppl 1):38-47. PubMed ID: 33024304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detecting MYB and MYBL1 fusion genes in tracheobronchial adenoid cystic carcinoma by targeted RNA-sequencing.
    Pei J; Flieder DB; Patchefsky A; Talarchek JN; Cooper HS; Testa JR; Wei S
    Mod Pathol; 2019 Oct; 32(10):1416-1420. PubMed ID: 31028361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solid-Basaloid Adenoid Cystic Carcinoma of the Breast: An Aggressive Subtype Enriched for Notch Pathway and Chromatin Modifier Mutations With MYB Overexpression.
    Shamir ER; Bean GR; Schwartz CJ; Vohra P; Wang A; Allard GM; Wolsky RJ; Garcia JJ; Chen YY; Krings G
    Mod Pathol; 2023 Dec; 36(12):100324. PubMed ID: 37660928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenoid cystic carcinoma of the lacrimal gland: MYB gene activation, genomic imbalances, and clinical characteristics.
    von Holstein SL; Fehr A; Persson M; Therkildsen MH; Prause JU; Heegaard S; Stenman G
    Ophthalmology; 2013 Oct; 120(10):2130-8. PubMed ID: 23725736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MYB expression and translocation in adenoid cystic carcinomas and other salivary gland tumors with clinicopathologic correlation.
    West RB; Kong C; Clarke N; Gilks T; Lipsick JS; Cao H; Kwok S; Montgomery KD; Varma S; Le QT
    Am J Surg Pathol; 2011 Jan; 35(1):92-9. PubMed ID: 21164292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.